All News

Officials with the FDA have requested that manufacturers of all ranitidine (Zantac) drugs, both prescription and over-the-counter, remove their products from the market. 

Bempedoic acid (Nexletol, Esperion), an oral, once-daily, non-statin low-density lipoprotein-cholesterol lowering medicine, is now available in US pharmacies.

The purpose of the project was to increase the number of influenza, pertussis, pneumococcal, and herpes zoster vaccines provided to adults.

As coronavirus cases surge nationwide, retail pharmacies are facing incredibly difficult circumstances.

Less common but more communicable than localized zoster

Ticagrelor alone, without aspirin, reduced bleeding without increasing the cardiovascular risks.

Concerns about adequate protection from COVID-19 have led to several efforts from chain pharmacies to keep pharmacy staff and employees safe.

Officials with the FDA have approved durvalumab (Imfinzi) for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC), in combination with standard-of-care (SoC) chemotherapies, in adult patients.

Alirocumab significantly reduced low-density lipoprotein cholesterol in adults with homozygous familial hypercholesterolemia, according to phase 3 data. 

Chloroquine and hydroxychloroquine have been authorized to treat hospitalized patients with COVID-19.

Abbott’s ID NOW COVID-19 test is able to deliver results in as little as 5 minutes.

Things to know about the root cause of chickenpox and shingles

Here’s a roundup of the latest coronavirus-related news from this week. 

Officials with the FDA have granted approval to ozanimod (Zeposia, Bristol Myers Squibb) for the treatment of relapsing multiple sclerosis.

Gilead has now asked the FDA to rescind its orphan drug status for the potential COVID-19 therapy.

Health care providers should look out for more than just respiratory diagnoses in patients when it comes to influenza-associated complications, according to a recent study. 

In a joint statement, the American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) have communicated concerns regarding the inappropriate ordering, prescribing, or dispensing of treatments for COVID-19.

Tissue plasminogen activator, which is used to treat blood clots, may help severely ill patients with COVID-19 who are in respiratory failure, according to a new paper.

CVS Caremark’s new quantity limits will not affect members who are already receiving these medications for their approved uses.

Convalescent plasma, hydroxychloroquine, and remdesivir among the potential COVID-19 treatment pathways being pursued.

A study investigated the use of lopinavir-ritonavir for the potential treatment of hospitalized patients with severe COVID-19.

The trials demonstrated a significant decrease in 24-hour coughs per hour versus placebo at 12 and 24 weeks.

Crisaborole ointment, 2% (Eucrisa, Pfizer) has been approved for use in pediatric patients with atopic dermatitis as young as 3 months of age.

After a steady climb, a new study showed that death rates for melanoma in the United States have dropped over the last few years.

The announcement follows their previous commitment to offering COVID-19 testing at local hospitals.

Pediatricians stress the importance of understanding the effects of COVID-19 on children.

Officials with the FDA have approved a 420-mg multi-dose of trastuzumab-bttb (Ontruzant, Samsung Bioepis), a biosimilar referencing trastuzumab (Herceptin).